Ambient Reagents Simplify NGS Automation

The reliance on cold-chain logistics for biologics is a significant source of both operational cost and environmental impact. The healthcare sector is responsible for 4.4% of global greenhouse gas emissions, with the pharmaceutical cold chain emitting 55% more greenhouse gases per dollar of revenue than the automotive industry. This is driven by energy-intensive refrigerated transport and single-use packaging like Styrofoam, which contributes to the 300 million tonnes of plastic waste the industry generates annually. Meridian's strategy centers on lyophilization, or freeze-drying, to create ambient-stable reagents that are rehydrated at the point of use. This technique eliminates performance variability caused by freeze-thaw cycles, a critical factor for ensuring reproducibility in automated, high-throughput NGS library preparation. The company's Lyophilized NGS Enzymatic DNA Fragmentation Kit is presented as the only commercially available ambient-stable solution for this specific NGS workflow step. The move towards such stable reagents directly supports the integration of genomics workflows with digital manufacturing systems. In cell and gene therapy, a single electronic batch record (EBR) can contain over 3,000 data points from donor qualification to final release. Integrating automated NGS platforms with LIMS and EBR systems is essential for maintaining data integrity and compliance in GxP environments. This push for efficiency comes as the CDMO market is projected to grow, reaching an estimated $368.7 billion by 2034. However, the broader biotech funding climate remains challenging, with investors prioritizing capital efficiency and de-risked, later-stage assets. Technologies that reduce operational overhead and improve process robustness are therefore critical for CDMOs aiming to maintain a competitive edge. Standardizing sample preparation with automation and stable reagents generates more consistent data, which is crucial for developing effective AI and machine learning models in bioprocessing. These high-quality datasets are the foundation for creating digital twins and predictive models to optimize bioreactor control, media formulation, and overall manufacturing yield.